Ionizing radiation

ROC STATUS: Known human carcinogens include X radiation and gamma radiation (since 2004), neutrons (since 2004), radon (since 1994), and thorium dioxide (since 1981)

ALSO KNOWN AS: Gamma radiation, X radiation

RELATED CANCERS: Lung, bone, bone marrow (leukemia), thyroid, breast, liver, skin, salivary glands, stomach, colon, bladder, ovary, and central nervous system.

94462183-94910.jpg

DEFINITION: Ionizing radiation is the energy released from the disintegration of unstable atomic nuclei during radioactive decay. This type of radiation may originate from X radiation or the emission of various subatomic particles from natural and artificial sources. Some substances decay faster than others and are more or less stable.

Exposure routes: Inhalation, ingestion, direct external exposure

Where found: Ionizing radiation is naturally occurring and artificially produced. It is found in radon (55 percent) and the Earth. Non-natural sources include military weapons, nuclear reactors, and electronic products. Technologically enhanced naturally occurring radioactive materials (TENORMs) concentrate ionizing radiation in solid sludge, water treatment facilities, aluminum oxide reactions, fertilizers, coal ash, concrete aggregates, diagnostic medical procedures, cable insulation, security screening equipment, and equipment used to kill microorganisms in food.

At risk: Children, pregnant women, industry workers, medical personnel, military personnel, residents in high background radiation areas

Etiology and symptoms of associated cancers: Ionizing radiation, regardless of the source, damages deoxyribonucleic acid (DNA, the genetic material) inside cells. Chromosomal breaks, cell mutations, and actual cell transformation can cause the damage—the consequences of this damage range from immediate cell death to malignant cells over time. The ability of ionizing radiation to kill cells explains its use to treat many cancers. Cancer cells divide more rapidly and are more vulnerable to radiation. Thus, ionizing radiation has the ability, when the trajectory of the beam is focused on a tumor, to shrink tumors by killing cells.

Immediate symptoms of exposure vary according to the type of particle, the dose, the length of exposure, and the route of exposure. Radiation sickness, or acute radiation syndrome, results from immediate excessive high-dose exposure. Whole-body penetration damages the cardiovascular and central nervous systems. The blood pressure drops (hypotension), and the brain swells. Nausea, vomiting, convulsions, and confusion will follow. Death is inevitable when exposure is greater than 3,000 rads.

History: In 1896, Henri Becquerel presented his discovery of radioactivity in Paris at the Academy of Sciences. During the 1900s, scientists Marie and Pierre Curie, Dmitry Mendeleyev, and Wilhelm Conrad Röntgen defined the properties of ionizing radiation. Many of the scientists working with ionizing radiation died as a result of their exposures. In 1970, the Environmental Protection Agency (EPA) began regulating ionizing radiation.

Bibliography

Ali, Yasser F., et al. "Cancer Risk of Low Dose Ionizing Radiation." Frontiers in Physics, vol. 8, 2020, p. 234. doi.org/10.3389/fphy.2020.00234.

Belotserkovsky, Eduard, and Ziven Ostaltsov. Ionizing Radiation: Applications, Sources, and Biological Effects. Nova, 2012.

DeWerd, L. A., and Michael Kissick. The Phantoms of Medical and Health Physics: Devices for Research and Development. Springer, 2014.

Hauptmann, Michael, et al. "Epidemiological Studies of Low-dose Ionizing Radiation and Cancer: Summary Bias Assessment and Meta-analysis." JNCI Monographs, vol. 56, 2020, pp. 188-200. doi.org/10.1093/jncimonographs/lgaa010.

"Ionizing Radiation and Health Effects." WHO, 27 July 2023, www.who.int/news-room/fact-sheets/detail/ionizing-radiation-and-health-effects. Accessed 20 June 2024.

"Radiation." National Cancer Institute, 2019, www.cancer.gov/about-cancer/causes-prevention/risk/radiation. Accessed 20 June 2024.

Ryan, Julie L. "Ionizing Radiation: The Good, the Bad, and the Ugly." Journal of Investigative Dermatology, vol. 132, 2012, pp. 985–93. doi.org/10.1038/jid.2011.411.